Regular Articles
Antioxidant and Lysosomotropic Properties of Acridine-propranolol: Protection against Oxidative Endothelial Cell Injury

https://doi.org/10.1006/jmcc.2001.1495Get rights and content

Abstract

The antioxidant and lysosomotropic properties of a fluorescent analogue of propranolol, 9-amino-acridine-propranolol (9-AAP) were compared to those of propranolol. Using isolated microsomal membranes exposed to a superoxide and hydroxyl radical generating system, 9-AAP was found to be at least 10-fold more potent than propranolol (and about 50% as potent as vitamin E) in inhibiting lipid peroxidation. In cultured endothelial cells, 9-AAP afforded moderate protective effect against acute loss of glutathione but potent cytoprotective activity against free radical-mediated loss of viability/survival. Intracellular localization of 9-AAP was examined by fluorescent microscopy and compared with two known fluorescent lysosomal markers: acridine orange and Lysosensor. All three agents appeared to localize to similar peri-nuclear vesicles, presumably lysosomes or pre-lysosomes. Lysosensor fluorescence was not observable in the presence of 9-AAP, foreclosing the possibility of a direct dual labeling experiment. We employed the pH sensitivity of acridine orange to determine if it labels the same vesicles as 9-AAP. When the endothelial cells were preloaded with acridine orange, washed and resuspended in buffer containing 9-AAP, the dark orange-labeled vesicles observed with acridine orange alone became increasingly lighter with time. Since the fluorescence of acridine orange is altered by pH change, this spectral shift in fluorescence emission is consistent with the indication that added propranolol (or the analog) leads to lysosomal alkalization. In conclusion, 9-AAP is both a strong antioxidant and a lysosomotropic agent that is remarkably insensitive to photobleaching . These properties may contribute to the enhanced endothelial cytoprotective effects against free radical-induced injury.

References (39)

  • JH Kramer et al.

    Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism

    J Mol Cell Cardiol

    (1991)
  • JB Lloyd et al.

    Evidence that desferrioxamine cannot enter cells by passive diffusion

    Biochem Pharmacol

    (1991)
  • G Balla et al.

    Ferritin: a cytoprotective antioxidant strategem of endothelium

    J Biol Chem

    (1992)
  • JK Brieland et al.

    Transferrin: a potential source of iron for oxygen free radical-mediated endothelial cell injury

    Arch Biochem Biophys

    (1992)
  • E Welman

    Stabilization of lysosomes in anoxic myocardium by propranolol

    Br J Pharmacol

    (1979)
  • Mak, IT, Weglicki, WB, Beta blockers with antioxidant properties: from propranolol to carvedilol, In Bellomo G, Finardi...
  • AV Chobanian et al.

    Effects of propranolol on atherogenesis in the cholesterol-fed rabbit

    Circ Res

    (1985)
  • JH Kramer et al.

    Lipid peroxidation-derived free radical production and post-ischemic myocardial reperfusion injury

    Ann NY Acad Sci

    (1994)
  • WB Weglicki et al.

    Antioxidants and the cardiomyopathy of Mg-deficiency

    Am J Cardiovascul Pathol

    (1992)
  • Cited by (0)

    f1

    Please address all correspondence to: I. Tong Mak, PhD, Department of Physiology and Experimental Medicine, Antioxidant Pharmacology Laboratory, The George Washington University Medical Center, 2300 Eye Street NW, Ross Hall, Rm 452, Washington DC, 20037, USA. Tel: 202-994-2865; E-mail: [email protected]

    View full text